The CDF 2024 Grant window is now open!
The 2024 Call for Proposals for Canadian Dermatology Foundation Grants is now open! We are happy to announce that Canadian Institutes for Health Research (CIHR) agreed to contribute to the grant pool this year. Submission deadline is 11:59 ET March 8th, 2024.
New in 2024
In the 2024 CDF Grant Competition we will have 4 categories of grants:
Funding: Up to $100,000 distributed over two years ($50,000 per year).
Criteria: Awarded to mature, well-developed projects with the highest scores in peer-review evaluations.
Funding: Up to $10,000 granted for a one-year period.
Eligibility: Open to residents enrolled in accredited Canadian dermatology residency programs.
Purpose: Support projects initiated by residents, fostering early contributions to dermatological research.
Pediatric Atopic Dermatitis Grants:
Funding: Two proposals considered at levels of $10,000 and $50,000.
Focus: Proposals addressing pediatric atopic dermatitis, particularly those serving underserved communities in Canada.
Operating Grants in Collaboration with SkIN Canada:
Funding: Up to two grants, each at $10,000.
Eligibility: Applicants must have secured SkIN Canada Team Development Grants.
Purpose: Facilitate multicenter team building, assisting in acquiring preliminary data to enhance the competitiveness of teams in future grant competitions.
Further documents and resources:
- 2024 CDF Grant Applications – Guidelines
- Application portal
- Grant writing tutorials. CDF plans to organize several grant writing courses which will be held at the planned CDF/CSID meetings. The dates for 2024 will be announced soon, please follow us on the website cdf.ca or Linkedin.
Transparent peer review:
Peer review process
The CDF adheres to CIHR grant review principles. Each grant undergoes evaluation by two independent reviewers: the primary and secondary. The primary reviewer presents the score and justification to the panel, followed by input from the secondary reviewer. Post additional discussion, each panel member assigns a score, with the average determining the final ranking for project assessment. This process ensures a meticulous evaluation aligned with rigorous medical research standards. The criteria for grant assessment can be accessed here.
The review panel, presided over by the CDF Scientific Chair, is tasked with safeguarding the fairness of the review process, with the chair refraining from participating in voting. To reinforce impartiality, non-voting observers will be invited, representing key stakeholders: CIHR, patient organizations, Canadian dermatology residents, and SKiN Canada. The identities of both the complete review panel and the observers will be disclosed publicly. This commitment to transparency ensures accountability and upholds the integrity of the evaluation procedures.
Conflict of interests
Every member of the review panel and observers will be required to disclose any potential conflicts of interest. In the event a conflict is identified, those specific reviewers and observers will be excused from participating in the deliberations and scoring of the relevant grants. However, they will remain actively involved in the evaluation of grants where no conflicts of interest arise.
Each applicant will receive a written review of their grant. Authors of unsuccessful grants may additionally obtain panel recommendations on enhancing the chances of success in the next competition. The CDF Scientific Chair will actively gather feedback from reviewers and observers, emphasizing aspects such as objectivity, impartiality, effectiveness, and relevance in the grant review process.
In order to safeguard intellectual property, the confidentiality of applicants and project details will be strictly maintained, except for the names and project titles of successful applications. Additionally, we will refrain from publishing the reviews or scores of the projects, ensuring a secure environment that respects and protects the intellectual contributions of all applicants.
CDF / CSID partnership
The Canadian Society of Investigative Dermatology (CSID) serves as a vital partner organization for CDF, concentrating on the dissemination of Canadian dermatological research. Additionally, we collaborate with SKiN Canada to foster network building and facilitate collaborations among researchers across the country. It is anticipated that successful applicants will showcase their research at CDF/CSID meetings, typically held during the annual gatherings of the Canadian Dermatology Association (CDA). This collaborative effort ensures the widespread dissemination and visibility of cutting-edge dermatological research within the Canadian Scientific community.